FGF23 signaling in hypophosphatemic rickets and related disorders

No Pathway Network information available for FGF23 signaling in hypophosphatemic rickets and related disorders

Pathways in the FGF23 signaling in hypophosphatemic rickets and related disorders SuperPath

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with FGF23 signaling in hypophosphatemic rickets and related disorders SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Hypophosphatemic ricketsEnrichmentDMP1, ENPP1, FGF23, PHEX9.66
2Tumoral calcinosis, hyperphosphatemic, familial, 1EnrichmentFGF23, GALNT3, KL8.43
3Hypophosphatemic rickets with hypercalciuria, hereditaryEnrichmentSLC34A1, SLC34A35.60
4Autosomal recessive hypophosphatemic ricketsEnrichmentDMP1, ENPP15.60
5Nephrolithiasis/osteoporosis, hypophosphatemic, 1EnrichmentSLC34A1, SLC34A35.60
6Autosomal recessive infantile hypercalcemiaEnrichmentCYP24A1, SLC34A15.60
7Crouzon syndromeEnrichmentFGFR2, FGFR35.12
8Lacrimoauriculodentodigital syndrome 1EnrichmentFGFR2, FGFR35.12
9Hypophosphatemic rickets, autosomal dominantEnrichmentFGF23, PHEX5.12
10Saethre-chotzen syndromeEnrichmentFGFR2, FGFR34.82
11Hemifacial hyperplasiaEnrichmentFGFR2, FGFR34.60
12Common variable immunodeficiencyEnrichmentNFKB1, NFKB24.28
13Giant cell glioblastomaEnrichmentFGFR3, ROS13.47
14Colorectal cancerEnrichmentCCND1, FGFR2, FGFR33.44
15CraniosynostosisEnrichmentFGFR2, FGFR33.33
16Bladder cancerEnrichmentCDKN1A, FGFR33.00
17HypochondroplasiaEnrichmentFGFR32.79
18Beare-stevenson cutis gyrata syndromeEnrichmentFGFR22.79
19Thanatophoric dysplasia, type iEnrichmentFGFR32.79
20Hypophosphatemic rickets, autosomal recessive, 1EnrichmentDMP12.79
21Muenke syndromeEnrichmentFGFR32.79
22Raine syndromeEnrichmentFAM20C2.79
23Scaphocephaly, maxillary retrusion, and impaired intellectual developmentEnrichmentFGFR22.79
24Hypophosphatasia, adultEnrichmentALPL2.79
25Apert syndromeEnrichmentFGFR22.79
26Hypophosphatasia, childhoodEnrichmentALPL2.79
27Thanatophoric dysplasia, type iiEnrichmentFGFR32.79
28Camptodactyly, tall stature, and hearing loss syndromeEnrichmentFGFR32.79
29Fanconi renotubular syndrome 2EnrichmentSLC34A12.79
30Bent bone dysplasia syndrome 1EnrichmentFGFR22.79
31Arterial calcification, generalized, of infancy, 1EnrichmentENPP12.79
32Tumoral calcinosis, hyperphosphatemic, familial, 3EnrichmentKL2.79
33Hypercalcemia, infantile, 2EnrichmentSLC34A12.79
34Crouzon syndrome with acanthosis nigricansEnrichmentFGFR32.79
35Ossification of the posterior longitudinal ligament of spineEnrichmentENPP12.79
36Hypophosphatemic rickets, autosomal recessive, 2EnrichmentENPP12.79
37Cole diseaseEnrichmentENPP12.79
38Achondroplasia, severe, with developmental delay and acanthosis nigricansEnrichmentFGFR32.79
39Tumoral calcinosis, hyperphosphatemic, familial, 2EnrichmentFGF232.79
40Deficiency in anterior pituitary function - variable immunodeficiency syndromeEnrichmentNFKB22.79
41Prenatal benign hypophosphatasiaEnrichmentALPL2.79
42Autosomal recessive hypophosphatemic bone diseaseEnrichmentSLC34A32.79
43Lacrimoauriculodentodigital syndrome 2EnrichmentFGFR32.79
44Fgfr3-related chondrodysplasiaEnrichmentFGFR32.79
45Camptodactyly-tall stature-scoliosis-hearing loss syndromeEnrichmentFGFR32.79
46Hypopigmentation-punctate palmoplantar keratoderma syndromeEnrichmentENPP12.79
47Non-syndromic unicoronal craniosynostosisEnrichmentFGFR22.79
48Hypoparathyroidism, familial isolated, 1EnrichmentPTH2.49
49Corticosterone methyloxidase type i deficiencyEnrichmentCYP11B22.49
50Cervical cancerEnrichmentFGFR32.49
51Corticosterone methyloxidase type ii deficiencyEnrichmentCYP11B22.49
52Hypercalcemia, infantile, 1EnrichmentCYP24A12.49
53Aural atresia, congenitalEnrichmentFGFR22.49
54Keratosis, seborrheicEnrichmentFGFR32.49
55Pfeiffer syndromeEnrichmentFGFR22.49
56Jackson-weiss syndromeEnrichmentFGFR22.49
57Factor xii deficiencyEnrichmentSLC34A12.49
58Immunodeficiency, common variable, 12, with autoimmunityEnrichmentNFKB12.49
59Immunodeficiency, common variable, 10EnrichmentNFKB22.49
60Antley-bixler syndrome without genital anomalies or disordered steroidogenesisEnrichmentFGFR22.49
61Alpha-thalassemia/impaired intellectual development syndrome, x-linkedEnrichmentALPL2.49
62HypophosphatemiaEnrichmentPHEX2.49
63Split hand-foot malformationEnrichmentFGFR22.49
64HypophosphatasiaEnrichmentALPL2.49
65Cervix carcinomaEnrichmentFGFR32.49
66Alpha thalassemia-x-linked intellectual disability syndromeEnrichmentALPL2.49
67Dystonia 28, childhood-onsetEnrichmentENPP12.49
68Autosomal dominant nonsyndromic deafnessEnrichmentFGFR22.49
69Arterial calcification of infancyEnrichmentENPP12.49
70Familial hypoaldosteronismEnrichmentCYP11B22.49
71Dominant hypophosphatemia with nephrolithiasis or osteoporosisEnrichmentSLC34A12.49
72Common variable immunodeficiency 12EnrichmentNFKB12.49
73Early-onset familial hypoaldosteronismEnrichmentCYP11B22.49
74Myeloma, multipleEnrichmentCCND1, FGFR32.44
75AchondroplasiaEnrichmentFGFR32.31
76Larsen syndromeEnrichmentFGFR32.31
77Hypophosphatasia, infantileEnrichmentALPL2.31
78Vitamin d hydroxylation-deficient rickets, type 1aEnrichmentCYP27B12.31
79Familial isolated hypoparathyroidismEnrichmentPTH2.31
80HamartomaEnrichmentFGFR32.31
81Testicular germ cell cancerEnrichmentFGFR32.31
82SpermatocytomaEnrichmentFGFR32.31
83Testicular cancerEnrichmentFGFR32.31
84Hypophosphatemic rickets, x-linked dominantEnrichmentPHEX2.19
85Immunodeficiency, common variable, 1EnrichmentNFKB22.19
86CholangiocarcinomaEnrichmentROS12.19
87Mantle cell lymphomaEnrichmentCCND12.19
88Non-syndromic bicoronal craniosynostosisEnrichmentFGFR32.19
89Pediatric systemic lupus erythematosusEnrichmentSPP12.19
90Primary hyperparathyroidismEnrichmentPTH2.19
91GliomaEnrichmentFGFR22.19
92Primary fanconi renotubular syndromeEnrichmentSLC34A12.19
93Von hippel-lindau syndromeEnrichmentCCND12.09
94Vitamin d-dependent rickets, type 2aEnrichmentPHEX2.09
95Hyperaldosteronism, familial, type iEnrichmentCYP11B22.01
96Split-hand/foot malformation 1EnrichmentFGFR22.01
97Testicular germ cell tumorEnrichmentFGFR32.01
98Pseudoxanthoma elasticumEnrichmentENPP12.01
99Lung squamous cell carcinomaEnrichmentFGFR32.01
10046,xy disorder of sex developmentEnrichmentFGFR32.01
101Nevus, epidermalEnrichmentFGFR31.95
102Multiple endocrine neoplasia, type iEnrichmentCDKN1A1.95
103Leukemia, chronic lymphocyticEnrichmentCCND11.79
104Meier-gorlin syndrome 1EnrichmentFGFR21.79
105Ciliary dyskinesia, primary, 3EnrichmentNFKB11.79
106NephrocalcinosisEnrichmentSLC34A11.79
107NephrolithiasisEnrichmentSLC34A11.79
108Primary bone dysplasiaEnrichmentFGFR31.79
109OsteochondrodysplasiaEnrichmentFGFR31.75
110Renal hypodysplasia/aplasia 3EnrichmentFGFR31.71
111Multiple sclerosisEnrichmentCYP27B11.65
112Lung cancer susceptibility 3EnrichmentROS11.65
113Osteogenesis imperfecta, type iiiEnrichmentSLC34A11.62
114HydrocephalusEnrichmentFGFR21.62
115GliosarcomaEnrichmentFGFR31.59
116Endometrial cancerEnrichmentFGFR21.47
117HepatoblastomaEnrichmentFGFR31.47
118Brittle bone disorderEnrichmentALPL1.44
119Connective tissue diseaseEnrichmentFGFR31.30
120Systemic lupus erythematosusEnrichmentSPP11.21
121Type 2 diabetes mellitusEnrichmentENPP11.18
122Gastric cancerEnrichmentFGFR21.17
123Body mass index quantitative trait locus 11EnrichmentENPP11.11
124HypertelorismEnrichmentFGFR21.09
125Congenital nervous system abnormalityEnrichmentFGFR30.80
126Nervous system diseaseEnrichmentFGFR30.80

Loading...
Loading...
Loading...